RhoH aSHM was found to contribute to cancer progression from FL or chronic lymphocytic leukaemia (CLL) to DLBCL, indicating that deregulation of RhoH protein expression is highly related to higher-grade lymphomas and might act as an important prognostic marker [43,44]. The gene discussed is RHOH; the disease is B-cell chronic lymphocytic leukemia.